Showing results (331-340 of 743) with videos related to

Sort By:
Pageof 75
Blood Cancer Journal|August 1, 2018
Phase 1/2 trial of ixazomib, cyclophosphamide and dexamethasone in patients with previously untreated symptomatic multiple myelomaShaji K Kumar, Francis K Buadi, Betsy LaPlant, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2020
Implications of MYC Rearrangements in Newly Diagnosed Multiple MyelomaNadine Abdallah, Linda B Baughn, S Vincent Rajkumar, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 6, 2019
Cytogenetic Features and Clinical Outcomes of Patients With Non-secretory Multiple Myeloma in the Era of Novel Agent Induction TherapyBharat Nandakumar, Shaji K Kumar, Angela Dispenzieri, et al.
Mayo Clinic Proceedings|March 6, 2021
Clinical Characteristics and Outcomes of Patients With Primary Plasma Cell Leukemia in the Era of Novel Agent TherapyBharat Nandakumar, Shaji K Kumar, Angela Dispenzieri, et al.
American Journal of Hematology|August 12, 2017
Efficacy of daratumumab-based therapies in patients with relapsed, refractory multiple myeloma treated outside of clinical trialsArjun Lakshman, Jithma P Abeykoon, Shaji K Kumar, et al.
Blood Cancer Journal|August 13, 2020
Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment responseNadine Abdallah, S Vincent Rajkumar, Patricia Greipp, et al.
Cancer Science|March 16, 2007
In vivo and in silico studies on single versus multiple transplants for multiple myelomaDavid Dingli, Jorge M Pacheco, Angela Dispenzieri, et al.
Pageof 75